1. Home
  2. XBIT vs SYPR Comparison

XBIT vs SYPR Comparison

Compare XBIT & SYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.35

Market Cap

74.4M

Sector

Health Care

ML Signal

HOLD

Logo Sypris Solutions Inc.

SYPR

Sypris Solutions Inc.

HOLD

Current Price

$2.56

Market Cap

72.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
SYPR
Founded
2005
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
74.4M
72.5M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
XBIT
SYPR
Price
$2.35
$2.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
26.1K
142.2K
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$82,294,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$1.79
52 Week High
$3.61
$4.74

Technical Indicators

Market Signals
Indicator
XBIT
SYPR
Relative Strength Index (RSI) 39.19 35.11
Support Level $2.35 $2.01
Resistance Level $2.41 $2.72
Average True Range (ATR) 0.06 0.32
MACD -0.01 -0.06
Stochastic Oscillator 13.79 4.24

Price Performance

Historical Comparison
XBIT
SYPR

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc provides products and engineering, design, and manufacturing services for a variety of critical infrastructure sectors, including energy, space, communications, defense, transport, chemical, and water. The company operates in two segments, Sypris Technologies and Sypris Electronics. Sypris Technologies segment includes the sale of forged, machined, welded and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications, whereas the Sypris Electronics segment includes revenue from circuit card and box build manufacturing, high reliability manufacturing and systems assembly and integration, for aerospace and defense, communications and space applications. The majority of revenue is derived from the Sypris Electronics segment.

Share on Social Networks: